KR950008080B1 - Hplc chiral column for optical resolution of racemic amino acids - Google Patents

Hplc chiral column for optical resolution of racemic amino acids Download PDF

Info

Publication number
KR950008080B1
KR950008080B1 KR1019920009855A KR920009855A KR950008080B1 KR 950008080 B1 KR950008080 B1 KR 950008080B1 KR 1019920009855 A KR1019920009855 A KR 1019920009855A KR 920009855 A KR920009855 A KR 920009855A KR 950008080 B1 KR950008080 B1 KR 950008080B1
Authority
KR
South Korea
Prior art keywords
amino acids
hplc
chiral
chiral column
racemic
Prior art date
Application number
KR1019920009855A
Other languages
Korean (ko)
Other versions
KR940000407A (en
Inventor
현명호
양덕호
윤능민
Original Assignee
현명호
양덕호
윤능민
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 현명호, 양덕호, 윤능민 filed Critical 현명호
Priority to KR1019920009855A priority Critical patent/KR950008080B1/en
Publication of KR940000407A publication Critical patent/KR940000407A/en
Application granted granted Critical
Publication of KR950008080B1 publication Critical patent/KR950008080B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A HPLC chiral column for optical resolution of racemic aminoacid is manufactured by dissolving N-carboxymethyl N-alkylaminoalcohol mono sodium salt or mono potassium salt in a mixt. solvent of water and an organic solvent; and circulating the obtd. soln. in C8 or C18 reversed phase column for HPLC. The N-carboxymethyl N-alkylaminoalcohol mono sodium salt or mono potassium salt is a deriv. of optically active aminoalcohol; and is prepd. by a reduction of an aminoacid.

Description

라세미 아미노산의 광학분할을 위한 HPLC 키랄칼럼HPLC Chiral Column for Optical Fractionation of Racemic Amino Acids

본 발명은 라세미 아미노산이나 라세미 히드록시 카르복시산과 같이 multidentate 리간드로 작용할 수 있는 라세미 화합물을 광학분할 하는데 사용할 수 있는 HPLC용 키랄칼럼의 제조에 관한 것이다.The present invention relates to the preparation of a chiral column for HPLC that can be used to optically split racemic compounds that can act as multidentate ligands, such as racemic amino acids or racemic hydroxy carboxylic acids.

이 HPLC 키랄칼럼을 구성하는 물질은 키랄선택자와 상업용 C8혹은 C18HPLC칼럼으로서, 긴 알킬기를 가지고 있는 키랄 선택자를 물과 유기용매의 혼합용매에 녹인 후 상업용 C8혹은 C18HPLC 칼럼을 통하여 흘려줌으로써 HPLC용 키랄칼럼을 제조할 수 있다.The material constituting the HPLC chiral column is a commercial C 8 or C 18 HPLC column with a chiral selector. The chiral selector having a long alkyl group is dissolved in a mixed solvent of water and an organic solvent, and then purified through a commercial C 8 or C 18 HPLC column. By pouring, chiral columns for HPLC can be prepared.

이때 사용 가능한 키랄 선택자로는 광학활성 아미노산 유도체나 키랄 크라운 에테르 혹은 (IS,2R)-norephedrine 유도체등이 사용된바 있으나 본 발명에서는 아미노산의 환원에 의하여 얻을 수 있는 아미노 알코홀의 유도체를 키랄 선택자로 사용하여 키랄선택성의 범위 및 키랄 선택성의 크기를 확장하였다.At this time, as the chiral selector, optically active amino acid derivatives, chiral crown ethers or (IS, 2R) -norephedrine derivatives have been used, but in the present invention, amino alcohol derivatives obtained by reduction of amino acids are used as chiral selectors. This extends the range of chiral selectivity and the magnitude of chiral selectivity.

여기에서 사용되는 키랄 선택자의 제조방법 및 과정을 설명하면 다음과 같다.Referring to the manufacturing method and process of the chiral selector used herein are as follows.

1. 키랄 선택자의 제조방법1. Manufacturing method of chiral selector

아미노 알코홀(alanial, leucinol, valinol, phenyglycnol등)을 예를 들면 triethylamine 존재하에서 lauroyl chloride와 반응시켜 N-lauroylamino alcohol을 얻는다.Amino alcohols (alanial, leucinol, valinol, phenyglycnol, etc.) are reacted with lauroyl chloride in the presence of triethylamine, for example, to obtain N-lauroylamino alcohol.

N-lauroylamino alcohol을 THF 용액내에서 LiAH₄와 반응시켜 N-dodecyl amino alcohol을 얻는다. 합성된 N-dodecylamino alcohol을 디클로로 메탄을 녹인후 propyleneoxide 존재하에서 ethylbromoacetate와 반응시켜 N-ethoxycarbonylmethy N-dodeylamino alcohol을 얻는다.N-lauroylamino alcohol is reacted with LiAH₄ in THF solution to obtain N-dodecyl amino alcohol. The synthesized N-dodecylamino alcohol is dissolved in dichloromethane and reacted with ethylbromoacetate in the presence of propyleneoxide to obtain N-ethoxycarbonylmethy N-dodeylamino alcohol.

최종적으로 N-ethoxycarbonylmethyl N-dodecylamino alcohol을 메탄올에 녹인후 IN NaOH(혹은 INKOH)용액으로 처리하여 가수분해 하면 N-carboxymethyl N-dodecylamino alcohol mono sodium salt가 얻어진다.Finally, N-ethoxycarbonylmethyl N-dodecylamino alcohol is dissolved in methanol and treated with IN NaOH (or INKOH) solution to hydrolyze to obtain N-carboxymethyl N-dodecylamino alcohol mono sodium salt.

합성된 염 2g 정도를 50ml의 몰-메탄올 혼합용매(1:1, v/v)에 녹인후 상업용 C HPLC 칼럼을 통하여 3시간동안 순환시키고 3시간 후 순수한 물로 흘려주면 라세미 아미노산 등의 라세미 화합물의 광학분할에 응용가능한 HPLC 키랄칼럼이 만들어진다.After dissolving about 2 g of the synthesized salt in 50 ml of a mol-methanol mixed solvent (1: 1, v / v), circulating through a commercial C HPLC column for 3 hours and flowing it with pure water after 3 hours, racemics such as racemic amino acids HPLC chiral columns are made that are applicable to the optical splitting of compounds.

이 HPLC 키랄칼럼에 의하여 라세미 아미노산이 광학분할될 때 광학분할에 중요한 역할을 하는 삼성분 착물의 구조 즉 C18알킬사슬에 소수성 결합을 하고 있는 키랄 선택자 Cu(II) 및 아미노산 사이의 삼성분 착물의 구조는 그림 1과 같을 것으로 예상된다. (R)-Alaninol을 출발물질로 사용하여 키랄 선택자를 합성하고 이 키랄 선택자를 C18HPLC칼럼을 통하여 3시간동안 순환시켜 키랄 칼럼을 제조한 후 이 키랄칼럼을 이용하여 라세미 아미노산과 라세미 카르복시산을 광학분할하였을 때 광학분할 결과의 예는 Table 1과 같다. 아래에 (R)-Alaninol을 출발물질로 사용하는 키랄 선택자 및 키랄칼럼의 자세한 제조 과정의 예를 제시한다.When the racemic amino acid is optically divided by the HPLC chiral column, the structure of the ternary complex, which plays an important role in the optical division, that is, the ternary complex between the chiral selector Cu (II) and the amino acid having a hydrophobic bond to the C 18 alkyl chain The structure of is expected to be as shown in Figure 1. A chiral selector was synthesized using (R) -Alaninol as a starting material, and the chiral selector was circulated for 3 hours through a C 18 HPLC column to prepare a chiral column, and then racemic amino acid and racemic carboxylic acid were obtained using this chiral column. Table 1 shows the results of optical splitting when optical splitting is performed. Below is an example of the detailed preparation of the chiral selector and chiral column using (R) -Alaninol as starting material.

(1) N-Lauroyl-(R)-alaninol의 합성.(1) Synthesis of N-Lauroyl- (R) -alaninol.

250ml의 둥근 바닥 플라스크에 CH₂Cl₂(50ml), triethylamine(8.9ml, 64mM) 및 (R)-Alaninol(5ml, 64mM)을 가한 후 여기에 20ml의 CH₂Cl₂에 녹아 있는 Lauroyl chloride (15ml, 64mM)을 천천히 가하고 상온에서 약 2시간 동안 저어준다.CH2Cl₂ (50ml), triethylamine (8.9ml, 64mM) and (R) -Alaninol (5ml, 64mM) were added to a 250ml round bottom flask, and slowly added Lauroyl chloride (15ml, 64mM) dissolved in 20ml CH₂Cl₂. Stir at room temperature for about 2 hours.

2시간 동안 저어준 후 반응 혼합물을 포화 NaHCO₃수용액으로 세 번 씻어 주고 무수 MgSO₄로 건조한 후 감압 농축하여 고체물질을 얻는다. 이 고체물질을 아세톤에 용해한 후 hexane을 조금씩 가하여 재결정하면 흰색 결정이 얻어진다.(13.5g, 80%수율)After stirring for 2 hours, the reaction mixture was washed three times with saturated aqueous NaHCO₃ solution, dried over anhydrous MgSO₄, and concentrated under reduced pressure to obtain a solid material. After dissolving this solid material in acetone, recrystallization by adding hexane gradually gave white crystals. (13.5g, 80% yield)

m.p. 70-72℃m.p. 70-72 ℃

H NMR(CDCl₃)δ0.8-1.5(m,24H), 2.1(t,2H), 3.5(s,2H), 3.9(m,2H), 6.0(s,1H)H NMR (CDCl₃) δ0.8-1.5 (m, 24H), 2.1 (t, 2H), 3.5 (s, 2H), 3.9 (m, 2H), 6.0 (s, 1H)

IR(KBr)cm-13300, 2925, 1640, 1548, 1462, 1387IR (KBr) cm -1 3300, 2925, 1640, 1548, 1462, 1387

(2) N-Dodecyl-(R)-alaninol의 합성(2) Synthesis of N-Dodecyl- (R) -alaninol

250ml의 2구 플라스크에 N-Lauroyl-(R)-alaninol(10g,38mM)과 LiAIH₄(6g)을 가한 후 0℃, 질소 기류하에서 건조한 THF(50ml)을 소량씩 첨가한다. THF를 다 가한 후 약 24시간동안 환류한다. 24시간 환류후 반응 혼합물을 실온으로 냉각하고 얼음 bath 조건에서 물을 첨가하여 반응을 종결시키고 감압 농축하여 THF를 제거한다. 여기에 CH₂Cl₂(70ml)를 가하고 물로 세 번 씻어준 후 무수 MgSO₄로 건조한 후 감압 농축하여 고체물질을 얻는다. 이 고체 물질을 CH₂Cl₂에 용해한 후 핵산을 소량씩 가하여 재결정하면 흰색 결정이 얻어진다.(7.6g, 83%수율)N-Lauroyl- (R) -alaninol (10 g, 38 mM) and LiAIH₄ (6 g) were added to a 250 ml two-necked flask, and a small amount of THF (50 ml) dried under nitrogen stream at 0 ° C. was added. After reaching THF, reflux for about 24 hours. After refluxing for 24 hours, the reaction mixture is cooled to room temperature, water is added under ice bath conditions to terminate the reaction, and concentrated under reduced pressure to remove THF. CH₂Cl₂ (70ml) was added thereto, washed three times with water, dried over anhydrous MgSO₄ and concentrated under reduced pressure to obtain a solid material. This solid material was dissolved in CH₂Cl₂ and recrystallized with a small amount of nucleic acid to give white crystals (7.6g, 83% yield).

m.p. 63-65℃m.p. 63-65 ℃

H NMR(CDCl₃)δ1.5(m,26H), 2.5(m,3H), 3.4(m,2H)H NMR (CDCl₃) δ1.5 (m, 26H), 2.5 (m, 3H), 3.4 (m, 2H)

IR(KBr)cm 3320, 3110, 2950, 1550, 1462, 1337.IR (KBr) cm 3320, 3110, 2950, 1550, 1462, 1337.

(3) N-Ethoxycarbonylmethyl N-Dodecyl-(R)-alaninol의 합성(3) Synthesis of N-Ethoxycarbonylmethyl N-Dodecyl- (R) -alaninol

250ml의 둥근 바닥 플라스크에 위에서 합성된 N-Dodecyl-(R)-alaninol(6g,24.8mM)을 가하고 50ml의 CH₂Cl₂에 용해한 후 Ethoxybromoacetate(25mM)와 Propyleneoxide(1ml)을 가하여 혼합물을 상온에서 저어준다.In a 250 ml round bottom flask, N-Dodecyl- (R) -alaninol (6 g, 24.8 mM) synthesized above was added, dissolved in 50 ml of CH₂Cl₂, and then Ethoxybromoacetate (25 mM) and Propyleneoxide (1 ml) were added and the mixture was stirred at room temperature.

약 7시간 저어주면 흰색 고체가 생성됨을 확인할 수 있으며 24시간 후 반응을 중단하고 거름종이로 흰색 고체를 걸러낸 후 여액을 물로 세 번 씻어준다. 물로 씻어낸 유기용액을 무수 MgSO₄로 건조한 후 관 크로마토그래피를 분리하면 흰색 결정이 얻어진다.(2.2g, 27%수율)Stir for about 7 hours, you can see that a white solid is produced. After 24 hours, stop the reaction, filter the white solid with filter paper, and wash the filtrate three times with water. The organic solution washed with water was dried over anhydrous MgSO₄, and then separated by column chromatography to obtain white crystals (2.2g, 27% yield).

m.p. 78-80℃m.p. 78-80 ℃

H NMR(CDCl₃)δ1.2(m,29H), 2.9(m,2H), 3.25(s,2H), 3.4(s,2H), 4.2(t,2H)H NMR (CDCl₃) δ1.2 (m, 29H), 2.9 (m, 2H), 3.25 (s, 2H), 3.4 (s, 2H), 4.2 (t, 2H)

IR(KBr)cm-12900, 1750, 1420, 1380.IR (KBr) cm -1 2900, 1750, 1420, 1380.

(4) N-Carboxymethyl N-(R)-alaninol Monosodium Salt의 합성(4) Synthesis of N-Carboxymethyl N- (R) -alaninol Monosodium Salt

50ml의 둥근 바닥 플라스크에 위에서 합성한 N-ethoxycarbonymethyl N-Dodecyl-(R)-alaninol(2.0g,6.08mM)을 가하고 20ml의 메탄올에 녹인다.In a 50 ml round bottom flask, N-ethoxycarbonymethyl N-Dodecyl- (R) -alaninol (2.0 g, 6.08 mM) synthesized above was added and dissolved in 20 ml of methanol.

여기에 Dropping funnel을 통하여 IN의 NaOH(메탄올 용액)을 천천히 가한다. 약 5시간 동안 실온에서 저어준 후 감압 농축하여 oil 형태의 생성물(1.8g)을 얻는다.Add NaOH (methanol solution) of IN slowly through the dropping funnel. Stir at room temperature for about 5 hours and concentrate under reduced pressure to give an oily product (1.8 g).

IR(KBr)cm-12900, 1620, 1480, 1410IR (KBr) cm -1 2900, 1620, 1480, 1410

2. 키랄칼럼의 제조방법2. Manufacturing method of chiral column

위에서 합성한 합성물, N-carboxymethl N-dodecyl-(R)-alaninol monosodium salt(1.8g)을 50ml의 물-메탄올(1:1) 혼합용매에 녹이고 HPLC용 C18역상 칼럼을 통하여 순환시킨다. 이때 HPLC의 유속은 0.8ml/min로 유지한다.The compound synthesized above, N-carboxymethl N-dodecyl- (R) -alaninol monosodium salt (1.8 g), is dissolved in 50 ml of water-methanol (1: 1) mixed solvent and circulated through a C 18 reversed phase column for HPLC. At this time, the flow rate of HPLC is maintained at 0.8 ml / min.

HPLC검출기인 UV검출기에 의하여 UV의 흡수가 일정하게 유지됨을 관찰한 후 물-메탄올(1:1) 혼합용매를 계속 흘려준다.After observing that the absorption of UV is kept constant by the UV detector, the HPLC detector, the water-methanol (1: 1) mixed solvent is continuously flowed.

이때의 HPLC유속은 0.3ml/min을 유지한다. 7시간후 이동상은 순수한 물로 바꾸고 5시간 동안 계속 흘려주면 라세미 아미노산의 광학분할에 사용 가능한 키랄칼럼이 얻어진다.At this time, the HPLC flow rate was maintained at 0.3 ml / min. After 7 hours, the mobile phase was changed to pure water and kept flowing for 5 hours to obtain a chiral column that can be used for optical division of racemic amino acids.

3. 키랄칼럼에 의한 라세미 아미노산의 광학분할.3. Optical division of racemic amino acids by chiral column.

물-메탄올 혹은 물-아세토니트릴의 적당한 혼합 용매에 (키랄 선택자를 칼럼상에 계속 유지하기 위하여 혼합용매에 있어서 유기용매의 조성은 20%를 초과하지 않는 것이 좋다) 적절한 양의 CuSO₄를 용해하여 (CuSO₄의 용해도를 고려하여 0.3mM 이하) 이동상을 만들고 제조된 HPLC 키랄칼럼을 통하여 흘려준다. 여기에 광학 분할 하고자 하는 라세미 아미노산이나 히드록시 카르복시산을 주입하면 두 광학 이성질체가 분리된다.Dissolve an appropriate amount of CuSO 메탄 in a suitable mixed solvent of water-methanol or water-acetonitrile (the composition of the organic solvent in the mixed solvent should not exceed 20% to keep the chiral selector on the column) ( Considering the solubility of CuSO ₄ below 0.3mM) mobile phase is made and flowed through the prepared HPLC chiral column. When the racemic amino acid or hydroxy carboxylic acid to be optically injected is injected, the two optical isomers are separated.

그림 1. C18알킬 사슬에 고정된 키랄 선택자와 Cu(II) 및 아미노산 사이에 형성된 삼성분 착화합물의 구조.Figure 1.Structure of a tertiary complex formed between a chiral selector immobilized on a C 18 alkyl chain and Cu (II) and an amino acid.

C18알킬 사슬과 (D)-아미노산의 R기 사이의 소수성 상호작용 때문에 (D)-아미노산이 키랄칼럼에 더 오래 머무른다.The (D) -amino acid stays longer in the chiral column because of the hydrophobic interaction between the C 18 alkyl chain and the R group of (D) -amino acid.

Table 1. (R)-Alaniol 유도체를 기저로한 키랄고정상에서 라세미 아미노산 및 라세미 히드록시 카르복시산의 광학분할.Table 1.Optical fractionation of racemic amino acids and racemic hydroxycarboxylic acids on chiral stationary phases based on (R) -Alaniol derivatives.

[표 1]TABLE 1

a : 이동상 1: 순수한물(0.25mM CuSO4), 2:메탄올-물(10:90, 0.25mM CuSO4)a: mobile phase 1: pure water (0.25 mM CuSO 4 ), 2: methanol-water (10:90, 0.25 mM CuSO 4 )

이상과 같이 본 발명의 키랄칼럼에 사용되는 키랄 선택자(Chiral selector)의 합성 및 키랄 선택자를 이용한 라세미 아미노산의 광학 분할의 유용하게 쓰일 수 있는HPLC용 키랄 고정상의 제조방법으로서 라세미 아미노산, 라세미 히드록시 카르복시산등과 같은 전이 금속이온과 여러자리에서 배위할 수 있는 라세미 화합물에 대하여 높은 입체 선택성을 보이며 제조가 비교적 쉬운 HPLC 키랄칼럼이 제조되는바 광학분할에 있어 본 발명에 제품의 활용도가 기대되는바 크다.As described above, as a method for preparing chiral stationary phase for HPLC, which is useful for the synthesis of chiral selectors used in the chiral column of the present invention and the optical separation of racemic amino acids using chiral selectors, racemic amino acids and racemic HPLC chiral columns with high stereoselectivity and relatively easy production are prepared for transition metal ions such as hydroxycarboxylic acids and racemic compounds that can be coordinated at various positions. It is big.

Claims (1)

아미노산의 환원반응로 얻어지는 광학활성 아미노알코홀의 유도체인 N-carboxymethyl N-alkiylaminoalcohol mono sodium mono potassium salt 혹은 N-carboxymethyl N-alkiylaminoalcohol mono sodium satl 혹은 mono potassium salt를 물과 유기용매의 혼합용매에 녹이고 HPLC용 C8혹은 C18역상칼럼을 통하여 순환시켜 라세미 아미노산의 광학분할에 사용 가능한 HPLC 키랄칼럼을 제조함을 특징으로 하는 라세미 아미노산의 광학분할을 위한 HPLC 키랄칼럼.N-carboxymethyl N-alkiylaminoalcohol mono sodium mono potassium salt or N-carboxymethyl N-alkiylaminoalcohol mono sodium satl or mono potassium salt, a derivative of optically active aminoalcohol obtained by reduction of amino acids, is dissolved in a mixed solvent of water and organic solvent HPLC chiral column for optical separation of racemic amino acids, characterized in that the circulating through a C 8 or C 18 reverse phase column to prepare an HPLC chiral column usable for optical division of racemic amino acids.
KR1019920009855A 1992-06-05 1992-06-05 Hplc chiral column for optical resolution of racemic amino acids KR950008080B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920009855A KR950008080B1 (en) 1992-06-05 1992-06-05 Hplc chiral column for optical resolution of racemic amino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920009855A KR950008080B1 (en) 1992-06-05 1992-06-05 Hplc chiral column for optical resolution of racemic amino acids

Publications (2)

Publication Number Publication Date
KR940000407A KR940000407A (en) 1994-01-03
KR950008080B1 true KR950008080B1 (en) 1995-07-25

Family

ID=19334301

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920009855A KR950008080B1 (en) 1992-06-05 1992-06-05 Hplc chiral column for optical resolution of racemic amino acids

Country Status (1)

Country Link
KR (1) KR950008080B1 (en)

Also Published As

Publication number Publication date
KR940000407A (en) 1994-01-03

Similar Documents

Publication Publication Date Title
KR100604699B1 (en) Process for the production of beraprost and its salts
JPS61289073A (en) Sulfonic acid ester
CN112154140B (en) Compound and application thereof in synthesizing Brivaracetam (Brivaracetam) bulk drug
EP0082049A2 (en) Ethers with chiral atoms in the organic rest groups, their preparation, their use in the resolution of alcohols or of certain hemiacetals, and compounds so resolved
KR950008080B1 (en) Hplc chiral column for optical resolution of racemic amino acids
EP0998470B1 (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
JP2515568B2 (en) Novel thiazolidine derivative
JP3701984B2 (en) Labeled cyclopropane derivative and process for producing the same
JP2007531704A5 (en)
CN111499660A (en) Chiral sulfonamide proline bifunctional catalyst and preparation method and application thereof
EP0419348A1 (en) Process for the synthesis of oxazolopyridinderivatives
KR0163770B1 (en) Process for the production of 3,4-epoxybutyrate and intermediate thereof
KR0136706B1 (en) Process for 3-amino pyrrolidine derivatives
JP2005220041A (en) Water-soluble transition metal-diamine complex, method for producing the same and use thereof
US6143900A (en) Stereoselective synthesis of oxazoline derivative
KR960008243B1 (en) Hetero cyclic compound
KR100397491B1 (en) Optically active (S)-benzoxazine derivatives and preparing method of the same
Angert et al. Mukaiyama Reactions of a Silyl Enol Ether with Heteroatom‐Substituted β‐Formyl Esters
KR100267596B1 (en) Method for stereoselective synthesis of oxazoline derivatives equivalent to beta-amino-lpha-hydroxy acid
FR2565584A1 (en) HEPTANOIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE
WO2019219758A1 (en) Processes in the preparation of polyunsaturated ketone compounds
US5162554A (en) Optically active enantiomers of substituted glyceraldehydes or glycidaldehydes formed as subtituted 1,5- dihydro-3H-2,4-benzodioxepines
KR100197163B1 (en) Process for producing halobutyric acid ester
KR100209299B1 (en) Novel aminocyclic compounds
JPH11509203A (en) Novel asymmetric synthesis of R and S warfarin and its analogous compounds

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020722

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee